CN100465181C - Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality - Google Patents
Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality Download PDFInfo
- Publication number
- CN100465181C CN100465181C CNB2006100274083A CN200610027408A CN100465181C CN 100465181 C CN100465181 C CN 100465181C CN B2006100274083 A CNB2006100274083 A CN B2006100274083A CN 200610027408 A CN200610027408 A CN 200610027408A CN 100465181 C CN100465181 C CN 100465181C
- Authority
- CN
- China
- Prior art keywords
- symmetric
- esteramides
- diphosphine ligand
- compounds
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates the synthesis of C2-bis ruthenium doublephosphine ligand. The invention uses (S)- (S)- 1, 1' - 2 (biphenyl phosphino)-2, 2'- 2[(S)- 4- isopropyl oxazolinyl] bis ruthenium as raw material. The invention comprises the following steps: at the action of trifluoroacetic acid, (S)- (S)- 1, 1' - 2 (biphenyl phosphino)-2, 2'- 2[(S)- 4- isopropyl oxazolinyl] bis ruthenium removing oxazoline, getting esteramides compound, then carrying out ester exchange or reduction alkylation, and getting the product. The ligand from the invention can be used in metallic catalysis asymmetric reaction, and the ligand has the good reaction active and stereoselectivity. The R is -Me, -Et.
Description
Technical field
The present invention relates to the synthetic method of the chiral ligand of chemical technology field, be specifically related to a kind of C
2-symmetric synthetic method with bis ruthenium Diphosphine Ligand of face chirality.
Technical background
The rapid rise of chiral drug industry mainly has benefited from the very big development that method of asymmetric synthesis is learned research, and conversely, chiral drug industry has promoted the research that method of asymmetric synthesis is learned again.The asymmetry catalysis organic synthesis is that obtaining chipal compounds the most effective also is one of best method.In the asymmetry catalysis organic synthesis, the key that can reach the high enantioselectivity of high reaction activity is the structure of chiral phosphine ligand.Therefore the exploitation of chiral phosphine ligand is the priority research areas that academia and industrial community are paid close attention to always.
1996, Zhang Wanbin and Ikeda merit group synthesized first and have only had face chirality C
2-symmetrical ferrocene P, the P-part, and successfully it is applied in the allyl substitution reaction, obtained optical yield up to 94%e.e.
As C
2-symmetry axis chiral ligand, in asymmetric catalysis, the size of the interfacial angle that chiral ligand and metal-complexing form influences the key factor of asymmetric induction in the catalyzed reaction often.The small conversion of this angle may greatly influence the stereoselectivity of asymmetric catalysis.Can infer, exactly can be for the part of ferrocene class by the conversion metallocene, regulating the distance of two cyclopentadiene interannulars, thereby formed interfacial angle (torsional angle) when changing part and metal-complexing finally changes the chirality field of catalyzed reaction.The present invention is under the guidance of this notion, and design has synthesized the novel C that only has the face chirality
2-symmetric bis ruthenium Diphosphine Ligand is by investigating the influence of the right title catalytic effect of interfacial angle in the face chirality, to filter out the new catalyst with high catalytic activity and wide universality.
Find through literature search, do not find identical with theme of the present invention or similar bibliographical information so far as yet prior art.
Summary of the invention
The objective of the invention is at the deficiencies in the prior art, a kind of C is provided
2-symmetric the synthetic method with bis ruthenium Diphosphine Ligand of face chirality makes it can filter out the face chirality ligand with better asymmetry catalysis effect.
The present invention is achieved by the following technical solutions, and the inventive method step is as follows:
(1) (S)-(S)-1,1 '-two (diphenylphosphino)-2,2 '-two [(S)-4-Yi Bing oxazolin base] ruthenocene behind Po Kai oxazoline ring under the trifluoroacetic acid effect directly and aceticanhydride react the esteramides compounds.
(2) esteramides compounds and various sodium alkoxide carry out transesterification reaction and obtain required target compound.
(3) the esteramides compounds obtains glycol under the effect of tetrahydrochysene lithium aluminium, obtains target compound through alkylation then, i.e. C
2-symmetric bis ruthenium Diphosphine Ligand with face chirality, its structural formula is as follows:
Wherein R is R=-Me, or-Et.
In the step (1), reaction is to be solvent with the tetrahydrofuran (THF), and trifluoroacetic acid is hydrolyzed under existing, and hydrolysate directly is dissolved in the methylene dichloride, is under the condition of alkali at pyridine, carries out acidylate with aceticanhydride, obtains the esteramides compounds.
In the step (2), reaction is that the esteramides compounds is dissolved in tetrahydrofuran (THF), and the pure sodium solution that moves into alcohol then is 12-24h in the room temperature reaction time.
In the step (3), the esteramides compounds is dissolved in the tetrahydrofuran (THF) and obtains glycol with tetrahydrochysene lithium aluminium reducing, and tetrahydrochysene lithium aluminium consumption is 6equiv., and the reaction times is 3h.
In the step (3), solvent used during the alkylation of glycol can be DMSO, DMF, and the reaction times is 8-48h.
In the step (3), used alkali is sodium hydroxide during alkylation, and consumption is 6equiv., and used alkylating agent is an alkyl sulfuric ester, and consumption is 3equiv..
Synthetic route of the present invention is as follows:
Wherein R is R=-Me ,-Et.
Institute of the present invention synthetic part, be only have a face chirality and C
2-symmetry is based on the biphosphine ligand of ruthenocene.Such part can be applicable in the asymmetric reaction of various metal catalytics, as asymmetric cyclopropanization reaction, allyl substitution reaction, functionalized or the alkene of non-functionalization and the hydrogenation of imine compound etc., have very high reactive behavior and stereoselectivity, have application promise in clinical practice.
Institute of the present invention synthetic part, be a kind of brand-new type have only the face chirality and C
2-symmetry is based on the biphosphine ligand of ruthenocene.Further can find out the rule between the part structure activity relationship and asymmetry catalysis effect in this field, serve as that guidance can design and synthesizes the broad spectrum catalyzer with high catalytic activity and high enantioselectivity a bit.
Embodiment
Provide embodiment in conjunction with technology contents of the present invention:
Embodiment one
1, the preparation of carboxylic acid amide esters (2)
(S)-(S)-1,1 '-two (diphenylphosphino)-2,2 '-two [(S)-and 4-Yi Bing oxazolin base] (1.65g 2mmol) is dissolved in tetrahydrofuran (THF) (40mL) to ruthenocene, add successively then entry (2mL), trifluoroacetic acid (3.8mL, 49.4mmol), anhydrous sodium sulphate Na
2SO
4(18.8g), the suspension stirred overnight at room temperature is filtered, steaming desolventizes, resistates be dissolved in methylene dichloride (40mL) add successively then pyridine (7.2mL, 89mmol), acetic anhydride (12.0mL, 76.4mmol), stirred overnight at room temperature, mixture is with methylene dichloride (80mL) dilution, respectively with dilute hydrochloric acid (10%), water, saturated common salt water washing, anhydrous magnesium sulfate drying, steaming desolventize target product 1.65g, y=82.8%.
1H?NMR(400MHz，CDCl
3):δ7.34-7.14(m，20H，ArH)，6.59-6.58(brs，2H，NH)，5.39(brs，2H，RcH)，4.83(brs，2H，RcH)，4.39-4.34(dd，J＝4Hz，15.6，2H，OCH)，4.05-4.01(dd，J＝3.6Hz，11.2Hz，2H，OCH)，3.90(m，2H，NCH)，3.82(brs，2H，FCH)，2.18-2.17(m，2H，Me
2CH)，2.16(s，6H，COCH
3)，1.02-1.00(d，J＝8.8Hz，6H，CH
3)，0.99-0.97(d，J＝8.8Hz，6H，CH
3).
2, ' two (diphenylphosphino)-2, (S)-(S)-1,1, the preparation of 2 '-two (methoxycarbonyl) ruthenocene (1)
Carboxylic acid amide esters (0.30g 0.32mmol) is dissolved in tetrahydrofuran (THF) (8mL), then under room temperature to wherein add by sodium (0.3g, 40equiv.) and the sodium methoxide solution that makes of methyl alcohol (10mL), stirred overnight at room temperature.Transferring pH with the methanol solution of 25% (v/v) acetic acid is neutrality, boil off solvent, dissolve with methylene dichloride (20mL), after water, saturated common salt water washing, anhydrous magnesium sulfate drying, except that after desolvating, the resistates column chromatography (ethyl acetate/petroleum ether=1:6), get light green solid 0.17g, y=71.5%
1H?NMR(400MHz，CDCl
3):δ?7.34-7.17(m，20H，ArH)，5.42-5.41(brs，2H，FcH)，4.70-4.67(t，J＝5.2Hz，2H，FcH)，3.87(brs，2H，FcH)，3.70(s，6H，OCH
3).
Embodiment two:
1, the preparation of carboxylic acid amide esters (2)
(S)-(S)-1,1 '-two (diphenylphosphino)-2,2 '-two [(S)-and 4-Yi Bing oxazolin base] (1.65g 2mmol) is dissolved in tetrahydrofuran (THF) (40mL) to ruthenocene, add successively then entry (2mL), trifluoroacetic acid (3.8mL, 49.4mmol), anhydrous sodium sulphate Na
2SO
4(18.8g), the suspension stirred overnight at room temperature is filtered, steaming desolventizes, resistates be dissolved in methylene dichloride (40mL) add successively then pyridine (7.2mL, 89mmol), acetic anhydride (12.0mL, 76.4mmol), stirred overnight at room temperature, mixture is with methylene dichloride (80mL) dilution, respectively with dilute hydrochloric acid (10%), water, saturated common salt water washing, anhydrous magnesium sulfate drying, steaming desolventize target product 1.65g, y=82.8%.
1H?NMR(400MHz，CDCl
3):δ?7.34-7.14(m，20H，ArH)，6.59-6.58(brs，2H，NH)，5.39(brs，2H，RcH)，4.83(brs，2H，RcH)，4.39-4.34(dd，J＝4Hz，15.6，2H，OCH)，4.05-4.01(dd，J＝3.6Hz，11.2Hz，2H，OCH)，3.90(m，2H，NCH)，3.82(brs，2H，FCH)，2.18-2.17(m，2H，Me
2CH)，2.16(s，6H，COCH
3)，1.02-1.00(d，J＝8.8Hz，6H，CH
3)，0.99-0.97(d，J＝8.8Hz，6H，CH
3).
2, (S)-(S)-I, 1 ' two (diphenylphosphino)-2, the preparation of 2 '-two (ethoxy carbonyl) ruthenocene
Carboxylic acid amide esters (0.335g 0.36mmol) is dissolved in tetrahydrofuran (THF) (20mL), then under room temperature to wherein add by sodium (0.6g, 70equiv.) and the alcohol sodium solution that makes of ethanol (40mL), stirred overnight at room temperature.Transferring pH with the methanol solution of 25% (v/v) acetic acid is neutrality, boil off solvent, dissolve with methylene dichloride (20mL), after water, saturated common salt water washing, anhydrous magnesium sulfate drying, except that after desolvating, the resistates column chromatography (ethyl acetate/petroleum ether=1:6), get light green solid 0.19g, y=73.7%
1H?NMR(400MHz，CDCl
3):δ?7.30-7.16(m，20H，ArH)，5.42-5.41(brs，2H，FcH)，4.78-4.79(t，J＝2.4Hz，2H，FcH)，4.24-4.08(m，4H，OCH
2)，3.84-3.83(brs，2H，FcH)，.1.13-1.10(s，6H，CH
3).
Embodiment three:
1, the preparation of carboxylic acid amide esters (2)
(S)-(S)-1,1 '-two (diphenylphosphino)-2,2 '-two [(S)-and 4-Yi Bing oxazolin base] (1.65g 2mmol) is dissolved in tetrahydrofuran (THF) (40mL) to ruthenocene, add successively then entry (2mL), trifluoroacetic acid (3.8mL, 49.4mmol), anhydrous sodium sulphate Na
2SO
4(18.8g), the suspension stirred overnight at room temperature is filtered, steaming desolventizes, resistates be dissolved in methylene dichloride (40mL) add successively then pyridine (7.2mL, 89mmol), acetic anhydride (12.0mL, 76.4mmol), stirred overnight at room temperature, mixture is with methylene dichloride (80mL) dilution, respectively with dilute hydrochloric acid (10%), water, saturated common salt water washing, anhydrous magnesium sulfate drying, steaming desolventize target product 1.65g, y=82.8%.
1H?NMR(400MHz，CDCl
3):δ?7.34-7.14(m，20H，ArH)，6.59-6.58(brs，2H，NH)，5.39(brs，2H，RcH)，4.83(brs，2H，RcH)，4.39-4.34(dd，J＝4Hz，15.6，2H，OCH)，4.05-4.01(dd，J＝3.6Hz，11.2Hz，2H，OCH)，3.90(m，2H，NCH)，3.82(brs，2H，FCH)，2.18-2.17(m，2H，Me
2CH)，2.16(s，6H，COCH
3)，1.02-1.00(d，J＝8.8Hz，6H，CH
3)，0.99-0.97(d，J＝8.8Hz，6H，CH
3).
2, (S)-(S)-I, 1 ' two (diphenylphosphino)-2, the preparation of 2 '-dihydroxymethyl ruthenocene
To the tetrahydrochysene lithium aluminium (46mg that is suspended in tetrahydrofuran (THF) (8mL), 6equiv.) add carboxylic acid amide esters (188mg in the system, 0.2mmol) tetrahydrofuran (THF) (2mL) solution, stir 2-3h under the room temperature, carefully with saturated metabisulfite solution quencher, dilute with the long-pending ethyl ester ethyl ester of triploid then under the ice-water bath, system is successively with 10% hydrochloric acid soln, saturated sodium bicarbonate solution, saturated common salt water washing, anhydrous sodium sulfate drying, the resistates column chromatography behind the evaporate to dryness gets product glycol 110mg, y=89.5%.
1H?NMR(400MHz，CDCl
3):δ?7.43-7.22(m，20H，Ar-H)，4.96(b，2H，RcH)，4.48(d，J＝12.8Hz，2H，-OCH
2)，4.23(b，2H，RcH)，4.05(d，J＝12.8Hz，-OCH
2)，3.92(b，2H，RcH)，3.34(b，2H，-OH).
3, (S)-(S)-I, 1 ' two (diphenylphosphino)-2, the preparation of 2 '-two (methoxymethyl) ruthenocene
Glycol (14mg, 0.022mmol) be dissolved in add among the DMF (5mL) sodium hydroxide (5mg, 6equiv.) and Me
2SO
4(8.4 μ L) reacts 8h between 20-50 ℃, system is diluted with methylene dichloride, and with washing, saturated common salt washing, anhydrous magnesium sulfate drying boils off solvent respectively, and the resistates column chromatography gets target compound 12.4mg, y=82.0%.
1H?NMR(400MHz，CDCl
3):δ?7.34-7.22(m，20H，Ar-H)，4.83(b，2H，RcH)，4.33-4.29(dd，J＝2.8，11.2Hz，2H，-OCH
2)，4.25(b，2H，RcH)，4.05(d，J＝11.2Hz，-OCH
2)，3.83(b，2H，RcH)，3.17(s，6H，-OCH
3).
Embodiment four:
1, the preparation of carboxylic acid amide esters (2)
(S)-(S)-1,1 '-two (diphenylphosphino)-2,2 '-two [(S)-and 4-Yi Bing oxazolin base] (1.65g 2mmol) is dissolved in tetrahydrofuran (THF) (40mL) to ruthenocene, add successively then entry (2mL), trifluoroacetic acid (3.8mL, 49.4mmol), anhydrous sodium sulphate Na
2SO
4(18.8g), the suspension stirred overnight at room temperature is filtered, steaming desolventizes, resistates be dissolved in methylene dichloride (40mL) add successively then pyridine (7.2mL, 89mmol), acetic anhydride (12.0mL, 76.4mmol), stirred overnight at room temperature, mixture is with methylene dichloride (80mL) dilution, respectively with dilute hydrochloric acid (10%), water, saturated common salt water washing, anhydrous magnesium sulfate drying, steaming desolventize target product 1.65g, y=82.8%.
1H?NMR(400MHz，CDCl
3):7.34-7.14(m，20H，ArH)，6.59-6.58(brs，2H，NH)，5.39(brs，2H，RcH)，4.83(brs，2H，RcH)，4.39-4.34(dd，J＝4Hz，15.6，2H，OCH)，4.05-4.01(dd，J＝3.6Hz，11.2Hz，2H，OCH)，3.90(m，2H，NCH)，3.82(brs，2H，FCH)，2.18-2.17(m，2H，Me
2CH)，2.16(s，6H，COCH
3)，1.02-1.00(d，J＝8.8Hz，6H，CH
3)，0.99-0.97(d，J＝8.8Hz，6H，CH
3).
2, (S)-(S)-I, 1 ' two (diphenylphosphino)-2, the preparation of 2 '-dihydroxymethyl ruthenocene
To the tetrahydrochysene lithium aluminium (46mg that is suspended in tetrahydrofuran (THF) (8mL), 6equiv.) add carboxylic acid amide esters (188mg in the system, 0.2mmol) tetrahydrofuran (THF) (2mL) solution, stir 2-3h under the room temperature, carefully with saturated metabisulfite solution quencher, dilute with the long-pending ethyl ester ethyl ester of triploid then under the ice-water bath, system is successively with 10% hydrochloric acid soln, saturated sodium bicarbonate solution, saturated common salt water washing, anhydrous sodium sulfate drying, the resistates column chromatography behind the evaporate to dryness gets product glycol 110mg, y=89.5%.
1H?NMR(400MHz，CDCl
3):δ?7.43-7.22(m，20H，Ar-H)，4.96(b，2H，RcH)，4.48(d，J＝12.8Hz，2H，-OCH
2)，4.23(b，2H，RcH)，4.05(d，J＝12.8Hz，-OCH
2)，3.92(b，2H，RcH)，3.34(b，2H，-OH).
3, (S)-(S)-I, 1 ' two (diphenylphosphino)-2, the preparation of 2 '-two (ethoxyl methyl) ruthenocene
Glycol (33mg, 0.05mmol) be dissolved in add among the DMSO (10mL) sodium hydroxide (12mg, 6equiv.) and Et
2SO
4(14.2 μ L 3equiv.), react 8h between 20-50 ℃, system is diluted with methylene dichloride, and with washing, saturated common salt washing, anhydrous magnesium sulfate drying boils off solvent respectively, and the resistates column chromatography gets target compound 27.9mg, y=78%.
1H?NMR(400MHz，CDCl
3):δ?7.51-7.19(m，20H，Ar-H)，4.83(b，2H，RcH)，4.35-4.32(dd，J＝11.6，2Hz，2H，RcCH
2)，4.26(b，2H，RcH)，4.10(d，J＝11.6Hz，2H，RcH)，3.82(b，2H，RcH)，3.40-3.24(m，4H，OCH
2)，0.89(t，J＝6.8，6H，-CH
3).
Claims (6)
1, a kind of C
2-symmetric the synthetic method with bis ruthenium Diphosphine Ligand of face chirality is characterized in that step is as follows:
(1) (S)-(S)-1,1 '-two (diphenylphosphino)-2,2 '-two [(S)-4-Yi Bing oxazolin base] ruthenocene under the trifluoroacetic acid effect and under the participation of water behind the Po Kai oxazoline ring directly and aceticanhydride react the esteramides compounds;
(2) esteramides compounds that obtains according to step (1) and various sodium alkoxide carry out transesterification reaction and obtain required target compound, and its structural formula is as follows:
(3) or the esteramides compounds that obtains according to step (1) under the effect of tetrahydrochysene lithium aluminium, obtain glycol, obtain target compound through alkylation then, i.e. C
2-symmetric bis ruthenium Diphosphine Ligand with face chirality, its structural formula is as follows:
Wherein R is-Me, or-Et.
2, C according to claim 1
2-symmetric synthetic method with bis ruthenium Diphosphine Ligand of face chirality; it is characterized in that; in the step (1); reaction is to be solvent with the tetrahydrofuran (THF); trifluoroacetic acid is hydrolyzed under existing, and hydrolysate directly is dissolved in the methylene dichloride, is under the condition of alkali at pyridine; carry out acidylate with aceticanhydride, obtain the esteramides compounds.
3, C according to claim 1
2-symmetric the synthetic method with bis ruthenium Diphosphine Ligand of face chirality is characterized in that, in the step (2), reaction is that the esteramides compounds is dissolved in tetrahydrofuran (THF), moves into the pure sodium solution of alcohol then in room temperature reaction 12-24 hour.
4, C according to claim 1
2-symmetric the synthetic method with bis ruthenium Diphosphine Ligand of face chirality is characterized in that, in the step (3), the esteramides compounds is dissolved in the tetrahydrofuran (THF) and obtains glycol with tetrahydrochysene lithium aluminium reducing, and tetrahydrochysene lithium aluminium consumption is 6 equivalents, and the reaction times is 3 hours.
5, C according to claim 1
2-symmetric the synthetic method with bis ruthenium Diphosphine Ligand of face chirality is characterized in that, in the step (3), used solvent is DMSO or DMF during alkylation, and the reaction times is 8-48 hour.
6, according to claim 1 or 5 described C
2-symmetric the synthetic method with bis ruthenium Diphosphine Ligand of face chirality is characterized in that, in the step (3), used alkali is sodium hydroxide during alkylation, and consumption is 6 equivalents, and used alkylating agent is an alkyl sulfuric ester, and consumption is 3 equivalents.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100274083A CN100465181C (en) | 2006-06-08 | 2006-06-08 | Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality |
| JP2009513539A JP5208928B2 (en) | 2006-06-08 | 2007-06-08 | C2-ruthenocene bisphosphine ligand having only symmetric planar chirality and its synthesis method |
| US12/303,767 US8507705B2 (en) | 2006-06-08 | 2007-06-08 | C2-symmetrical ruthenocene diphosphine ligands only with surface chirality and their manufacture |
| PCT/CN2007/001824 WO2007140717A1 (en) | 2006-06-08 | 2007-06-08 | C2-symmetrical ruthenocene diphosphine ligands only with surface chirality and their manufacture. |
| CNA2007800211231A CN101466718A (en) | 2006-06-08 | 2007-06-08 | C2Bis ruthenium diphosphine ligand with symmetry and only surface chirality and synthesis method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100274083A CN100465181C (en) | 2006-06-08 | 2006-06-08 | Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1876667A CN1876667A (en) | 2006-12-13 |
| CN100465181C true CN100465181C (en) | 2009-03-04 |
Family
ID=37509247
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100274083A Expired - Fee Related CN100465181C (en) | 2006-06-08 | 2006-06-08 | Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality |
| CNA2007800211231A Pending CN101466718A (en) | 2006-06-08 | 2007-06-08 | C2Bis ruthenium diphosphine ligand with symmetry and only surface chirality and synthesis method thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007800211231A Pending CN101466718A (en) | 2006-06-08 | 2007-06-08 | C2Bis ruthenium diphosphine ligand with symmetry and only surface chirality and synthesis method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN100465181C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8507705B2 (en) | 2006-06-08 | 2013-08-13 | Shanghai Jiaotong University | C2-symmetrical ruthenocene diphosphine ligands only with surface chirality and their manufacture |
| CN101143818A (en) * | 2007-09-27 | 2008-03-19 | 上海交通大学 | Enantioselectivity reversion method for allyl substitution reaction catalyzed by Pd |
| CN102951981A (en) * | 2011-08-22 | 2013-03-06 | 上海交通大学 | Asymmetric hydrogenation method for ketone compound |
| CN112824423B (en) * | 2019-11-21 | 2023-01-13 | 中国科学院大连化学物理研究所 | Chiral ferrocenylphosphine-indolylaminophosphine ligand and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166835A (en) * | 1994-11-29 | 1997-12-03 | 隆萨股份公司 | Method of producing optically active metallocenyl phosphines |
| JP2000256384A (en) * | 1999-03-02 | 2000-09-19 | Fuji Chemical Industries Ltd | Mew asymmetric ligand |
| WO2004099226A1 (en) * | 2003-05-09 | 2004-11-18 | Umicore Ag & Co. Kg | Substituted ferrocenyldiphosphines as ligands for homogeneous hydrogenation catalysts |
| JP2005047883A (en) * | 2003-07-31 | 2005-02-24 | Shinko Kagaku Kogyo Kk | Method for producing bis(ethylcyclopentadienyl)ruthenium |
-
2006
- 2006-06-08 CN CNB2006100274083A patent/CN100465181C/en not_active Expired - Fee Related
-
2007
- 2007-06-08 CN CNA2007800211231A patent/CN101466718A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166835A (en) * | 1994-11-29 | 1997-12-03 | 隆萨股份公司 | Method of producing optically active metallocenyl phosphines |
| JP2000256384A (en) * | 1999-03-02 | 2000-09-19 | Fuji Chemical Industries Ltd | Mew asymmetric ligand |
| WO2004099226A1 (en) * | 2003-05-09 | 2004-11-18 | Umicore Ag & Co. Kg | Substituted ferrocenyldiphosphines as ligands for homogeneous hydrogenation catalysts |
| JP2005047883A (en) * | 2003-07-31 | 2005-02-24 | Shinko Kagaku Kogyo Kk | Method for producing bis(ethylcyclopentadienyl)ruthenium |
Non-Patent Citations (2)
| Title |
|---|
| Highly Diastereoselective ortho-Lithiation of....... Wanbin Zhang, et al.Tetrahedron: Asymmetry,Vol.7 No.2. 1996 |
| Highly Diastereoselective ortho-Lithiation of…… Wanbin Zhang, et al.Tetrahedron: Asymmetry,Vol.7 No.2. 1996 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101466718A (en) | 2009-06-24 |
| CN1876667A (en) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101792400B (en) | Synthetic method for agomelatine | |
| CN101570550B (en) | Method for synthesizing chiral ferrocene diphosphine ligand | |
| CN100465181C (en) | Synthesis method of C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality | |
| US20090286997A1 (en) | Process for preparing arylaminopropanols | |
| Shi et al. | General rhodium-catalyzed oxidative cross-coupling reactions between anilines: synthesis of unsymmetrical 2, 2′-diaminobiaryls | |
| CN103664677A (en) | Asymmetric synthesis method of (R,R)-formoterol tartrate | |
| CN101265271B (en) | Method for synthesizing penem-like pharmaceutical intermediate 4AA | |
| CN111229311B (en) | Supported imidazole ionic liquid catalyst and method for synthesizing 2-amino-3-cyano-4H-pyran compounds | |
| CN100389118C (en) | C2-symmetrical bis ruthenium Diphosphine Ligand only with surface chirality | |
| CN103204801A (en) | Synthesis method for N-Boc-3-piperidone | |
| CN106831441B (en) | A kind of preparation method of cinacalcet hydrochloride | |
| CN101133011A (en) | Process for the manufacture of substituted propionic acids | |
| CN101074207B (en) | Soluble chiral diamino derivative, its production and use | |
| CN113444057B (en) | Single chiral arm aminophenol sulfonamide ligand and application thereof in asymmetric catalysis | |
| CN101774874B (en) | N-arylating method using pyrrole-2-hydrazide compound as ligand in aqueous phase system | |
| CN103159677A (en) | 1-phenyl-1, 2, 3, 4-tetrahydroisoquinoline preparation method | |
| CN106111190B (en) | A kind of chirality biaryl skeleton pyridoxamine class catalyst and its synthetic method and application | |
| CN102491947A (en) | Axial chiral imidazole salt compound and preparation method thereof | |
| CN103435505A (en) | Method for synthesizing -salmeterol | |
| US9328079B2 (en) | Process for producing optically active amine | |
| CN100381451C (en) | C2-symmetrical chirality bis ruthenium ligand and its synthesis method | |
| CN108101740A (en) | A kind of method that fragrance alkynes one kettle way is directly translated into chiral alcohol | |
| CN102863373B (en) | Method for synthesizing 5-benzylazaspiro[2,4]heptane | |
| CN102731388B (en) | Method for preparing (R)/(S)-6,6'-dihydroxy-5,5'-biquinoline | |
| CN106008336A (en) | Preparation method of 4-chloro-6,7-dimethoxyquinoline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090304 Termination date: 20170608 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |